Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 79,635 | 85,366 | -58,789 | -48,475 | -29,867 |
| Depreciation Amortization | 2,398 | 1,040 | 1,754 | 1,093 | 665 |
| Accounts receivable | -28,379 | -7,656 | 96 | 267 | 280 |
| Accounts payable and accrued liabilities | 3,691 | 2,577 | 1,756 | 1,306 | 3,477 |
| Other Working Capital | -39,591 | 5,001 | 403 | -4,190 | -1,825 |
| Other Operating Activity | 27,743 | 6,530 | 2,955 | 1,801 | -1,662 |
| Operating Cash Flow | $45,497 | $92,858 | $-51,825 | $-48,198 | $-28,932 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -122,913 | -37,732 | -88,820 | -41,078 | -71,021 |
| PPE Investments | -1,241 | -319 | -1,686 | -1,271 | -408 |
| Investing Cash Flow | $-124,154 | $-38,051 | $-90,506 | $-42,349 | $-71,429 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 7,555 | 7,555 | 7,555 |
| Debt Repayment | 0 | 0 | -3,278 | -3,278 | -3,278 |
| Common Stock Issued | 113,879 | 478 | 138,555 | 81,026 | 80,811 |
| Financing Cash Flow | $113,879 | $478 | $142,832 | $85,303 | $85,088 |
| Beginning Cash Position | 45,791 | 45,791 | 45,290 | 45,290 | 45,290 |
| End Cash Position | 81,013 | 101,076 | 45,791 | 40,046 | 30,017 |
| Net Cash Flow | $35,222 | $55,285 | $501 | $-5,244 | $-15,273 |
| Free Cash Flow | |||||
| Operating Cash Flow | 45,497 | 92,858 | -51,825 | -48,198 | -28,932 |
| Capital Expenditure | -1,241 | -319 | -1,686 | -1,271 | -408 |
| Free Cash Flow | 44,256 | 92,539 | -53,511 | -49,469 | -29,340 |